Granulocytes and No-Reflow Phenomenon in Irreversible Hemorrhagic Shock

Recent evidence shows that circulating granulocytes play an important role in capillary stasis and tissue injury. We investigated two aspects of the problem in a Wiggers hemorrhagic shock model of the ratthe survival rate and the microvascular no-reflow phenomenon. A conventional group of rats with...

Full description

Saved in:
Bibliographic Details
Published inCirculation research Vol. 63; no. 2; pp. 437 - 447
Main Authors Barroso-Aranda, Jorge, Schmid-Schönbein, Geert W, Zweifach, Benjamin W, Engler, Robert L
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.08.1988
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recent evidence shows that circulating granulocytes play an important role in capillary stasis and tissue injury. We investigated two aspects of the problem in a Wiggers hemorrhagic shock model of the ratthe survival rate and the microvascular no-reflow phenomenon. A conventional group of rats with normal blood cells and a neutropenic group of rats pretreated with intraperitoneal antigranulocyte antibody were used to evaluate the effects of granulocytes. Two hemorrhagic shock protocols (HSP) were carried out. In HSP-1, the rats were subjected to 40 mm Hg mean arterial pressure for 3 hours. The conventional group (n = 11) showed a 36% survival rate compared with 100% in the neutropenic group (n = 6). In HSP-2, the hypotension was more severe, 30 mm Hg mean arterial pressure for 7 hours. There were no survivors in the conventional group (n = 8), compared with a 100% survival rate in the neutropenic group (n = 6). The extent, location, and mechanism of the no-reflow phenomenon was investigated by examining histological sections from several organs after infusion of a contrast medium to mark vessels with flow in a control group without shock and in the HSP-2 model 2 hours after blood replacement. The arterioles and venules uniformly contained contrast medium in all three groups; only capillaries showed no-reflow. A significantly higher percentage of no-reflow was observed in the capillaries of the conventional shock group than in the neutropenic shock group. We concluded that the obstruction of capillaries was largely due to trapped granulocytes, suggesting that these leukocytes play a key role in the capillary no-reflow phenomenon and survival from hemorrhagic shock.
AbstractList Recent evidence shows that circulating granulocytes play an important role in capillary stasis and tissue injury. We investigated two aspects of the problem in a Wiggers hemorrhagic shock model of the rat: the survival rate and the microvascular no-reflow phenomenon. A conventional group of rats with normal blood cells and a neutropenic group of rats pretreated with intraperitoneal antigranulocyte antibody were used to evaluate the effects of granulocytes. Two hemorrhagic shock protocols (HSP) were carried out. In HSP-1, the rats were subjected to 40 mm Hg mean arterial pressure for 3 hours. The conventional group (n = 11) showed a 36% survival rate compared with 100% in the neutropenic group (n = 6). In HSP-2, the hypotension was more severe, 30 mm Hg mean arterial pressure for 7 hours. There were no survivors in the conventional group (n = 8), compared with a 100% survival rate in the neutropenic group (n = 6). The extent, location, and mechanism of the no-reflow phenomenon was investigated by examining histological sections from several organs after infusion of a contrast medium to mark vessels with flow in a control group without shock and in the HSP-2 model 2 hours after blood replacement. The arterioles and venules uniformly contained contrast medium in all three groups; only capillaries showed no-reflow. A significantly higher percentage of no-reflow was observed in the capillaries of the conventional shock group than in the neutropenic shock group. We concluded that the obstruction of capillaries was largely due to trapped granulocytes, suggesting that these leukocytes play a key role in the capillary no-reflow phenomenon and survival from hemorrhagic shock.
Recent evidence shows that circulating granulocytes play an important role in capillary stasis and tissue injury. We investigated two aspects of the problem in a Wiggers hemorrhagic shock model of the ratthe survival rate and the microvascular no-reflow phenomenon. A conventional group of rats with normal blood cells and a neutropenic group of rats pretreated with intraperitoneal antigranulocyte antibody were used to evaluate the effects of granulocytes. Two hemorrhagic shock protocols (HSP) were carried out. In HSP-1, the rats were subjected to 40 mm Hg mean arterial pressure for 3 hours. The conventional group (n = 11) showed a 36% survival rate compared with 100% in the neutropenic group (n = 6). In HSP-2, the hypotension was more severe, 30 mm Hg mean arterial pressure for 7 hours. There were no survivors in the conventional group (n = 8), compared with a 100% survival rate in the neutropenic group (n = 6). The extent, location, and mechanism of the no-reflow phenomenon was investigated by examining histological sections from several organs after infusion of a contrast medium to mark vessels with flow in a control group without shock and in the HSP-2 model 2 hours after blood replacement. The arterioles and venules uniformly contained contrast medium in all three groups; only capillaries showed no-reflow. A significantly higher percentage of no-reflow was observed in the capillaries of the conventional shock group than in the neutropenic shock group. We concluded that the obstruction of capillaries was largely due to trapped granulocytes, suggesting that these leukocytes play a key role in the capillary no-reflow phenomenon and survival from hemorrhagic shock.
Author Schmid-Schönbein, Geert W
Zweifach, Benjamin W
Barroso-Aranda, Jorge
Engler, Robert L
AuthorAffiliation From the AMES-Bioengineering, University of California, San Diego, La Jolla, California, the Department of Medicine, University of California, San Diego, and VA Medical Center, San Diego, California
AuthorAffiliation_xml – name: From the AMES-Bioengineering, University of California, San Diego, La Jolla, California, the Department of Medicine, University of California, San Diego, and VA Medical Center, San Diego, California
Author_xml – sequence: 1
  givenname: Jorge
  surname: Barroso-Aranda
  fullname: Barroso-Aranda, Jorge
  organization: From the AMES-Bioengineering, University of California, San Diego, La Jolla, California, the Department of Medicine, University of California, San Diego, and VA Medical Center, San Diego, California
– sequence: 2
  givenname: Geert
  surname: Schmid-Schönbein
  middlename: W
  fullname: Schmid-Schönbein, Geert W
– sequence: 3
  givenname: Benjamin
  surname: Zweifach
  middlename: W
  fullname: Zweifach, Benjamin W
– sequence: 4
  givenname: Robert
  surname: Engler
  middlename: L
  fullname: Engler, Robert L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/3396160$$D View this record in MEDLINE/PubMed
BookMark eNo9kEFP3DAQhS1ERRfKmRNSTr0ljD2J4xwrBAsSAgTcLceZkIATU3vDin9fV7vi8DR6em_e4Ttmh7OfibEzDgXnkl8AL56unguJhShKrA_YileizMuq5odsBQBNXiPCT3Yc4xsAL1E0R-wIsZFcwoqt18HMi_P2a0MxM3OX3fv8iXrnt9njQLOfkuZsnLPbEOiTQhxbR9kNTT6EwbyONnsevH3_xX70xkU63d8T9nJ99XJ5k989rG8v_9zltuSlyjvV1G2LUtoKqwqVqKmVrSXgtusrNJUkJaHrbW1bqAUJVBYkGimTE4gn7Pdu9iP4vwvFjZ7GaMk5M5Nfoq4V8gpUmYoXu6INPsZAvf4I42TCl-ag_5PTwHUipyVqoRO59HG-n17aibrv_h5VystdvvVukzi8u2VLQQ9k3GbQiTQgcJHzRilQyeVJXOE_YLN56A
CitedBy_id crossref_primary_10_1177_000331979304400108
crossref_primary_10_1016_0167_4889_95_00161_1
crossref_primary_10_1097_00003246_199610000_00021
crossref_primary_10_1097_00003246_199907000_00027
crossref_primary_10_1152_ajpheart_1999_276_6_H2035
crossref_primary_10_1007_BF00053553
crossref_primary_10_1517_13543784_3_7_709
crossref_primary_10_1016_0024_3205_91_90596_4
crossref_primary_10_1016_0022_4804_92_90120_O
crossref_primary_10_1016_S0039_6060_98_70206_5
crossref_primary_10_1016_S1056_8727_99_00040_9
crossref_primary_10_1139_o95_054
crossref_primary_10_1097_SHK_0000000000000048
crossref_primary_10_1097_00005373_199708000_00017
crossref_primary_10_1080_10739680590896009
crossref_primary_10_1097_00005373_200108000_00036
crossref_primary_10_1016_j_jss_2009_03_028
crossref_primary_10_1097_01_shk_0000227907_56060_2b
crossref_primary_10_1016_0049_3848_92_90152_Z
crossref_primary_10_1016_0300_9572_89_90022_1
crossref_primary_10_3390_medicina59112026
crossref_primary_10_1097_ALN_0000000000002008
crossref_primary_10_1097_00004647_199611000_00004
crossref_primary_10_1007_s002689900212
crossref_primary_10_1016_0049_3848_96_00055_2
crossref_primary_10_1016_0022_4804_92_90318_T
crossref_primary_10_1007_BF02584425
crossref_primary_10_1016_0300_9572_89_90027_0
crossref_primary_10_3109_08820539909069542
crossref_primary_10_1152_ajpgi_2002_282_4_G647
crossref_primary_10_1097_SHK_0000000000002099
crossref_primary_10_1097_00005373_199607000_00021
crossref_primary_10_1111_j_1749_6632_1997_tb46259_x
crossref_primary_10_1097_01_shk_0000055240_25446_16
crossref_primary_10_1016_0883_9441_92_90004_Q
crossref_primary_10_1016_0883_9441_92_90016_Z
crossref_primary_10_1016_S0049_3848_10_80004_0
crossref_primary_10_1016_0891_5849_96_00156_6
crossref_primary_10_1073_pnas_97_4_1772
crossref_primary_10_1002_jnr_490290309
crossref_primary_10_1016_0022_4804_91_90033_I
crossref_primary_10_1177_000331979504600402
crossref_primary_10_1038_jcbfm_1989_73
crossref_primary_10_1152_jappl_1998_85_6_2135
crossref_primary_10_1590_S0004_28032006000100015
crossref_primary_10_1097_00003246_199701000_00030
crossref_primary_10_1097_00003246_199909000_00070
crossref_primary_10_1177_1358863X12459790
crossref_primary_10_3109_02713689509033518
crossref_primary_10_1097_01_shk_0000235139_20775_7f
crossref_primary_10_1097_TA_0b013e3182211286
crossref_primary_10_1007_BF02989814
crossref_primary_10_1080_10739680500466228
crossref_primary_10_1152_ajpheart_2000_279_2_H791
crossref_primary_10_1016_S0011_3840_05_80008_5
crossref_primary_10_1016_S0928_4680_01_00064_5
crossref_primary_10_1007_s00101_007_1300_z
crossref_primary_10_1016_0014_2999_91_90173_N
crossref_primary_10_1097_01_CCM_0000201900_01000_6B
crossref_primary_10_1097_SHK_0b013e31819e13b1
crossref_primary_10_1097_00003246_200301000_00030
crossref_primary_10_1007_s100169900123
crossref_primary_10_1152_ajplung_1997_273_5_L1058
crossref_primary_10_1016_0952_3278_95_90095_0
crossref_primary_10_1152_ajpheart_1998_274_3_H1009
crossref_primary_10_1016_0022_4804_91_90090_9
crossref_primary_10_1016_0146_2806_94_90016_7
crossref_primary_10_1016_S1164_6756_96_80034_X
crossref_primary_10_1038_ki_1990_223
crossref_primary_10_1016_j_ihj_2016_12_012
crossref_primary_10_1016_0090_6980_94_90083_3
crossref_primary_10_1152_ajpregu_00650_2006
crossref_primary_10_1096_fj_00_0183com
crossref_primary_10_1177_088506669100600604
crossref_primary_10_1016_S0002_9610_02_01425_3
crossref_primary_10_1016_0022_4804_92_90073_9
crossref_primary_10_1016_0141_5425_89_90097_6
crossref_primary_10_1097_00004836_199800001_00013
crossref_primary_10_1111_j_1440_1746_1995_tb01602_x
crossref_primary_10_1213_00000539_200202000_00012
crossref_primary_10_1007_BF01880658
crossref_primary_10_3109_02713689309001830
crossref_primary_10_1016_S0741_5214_99_70131_X
crossref_primary_10_1152_ajpheart_1997_273_5_H2361
crossref_primary_10_3233_BIR_17131
crossref_primary_10_1097_00000539_200202000_00012
crossref_primary_10_1111_j_1476_4431_2004_04004_x
crossref_primary_10_1006_jsre_1999_5758
crossref_primary_10_1016_0022_4804_91_90051_M
crossref_primary_10_1016_j_jss_2009_09_007
crossref_primary_10_1152_ajplung_1999_276_5_L844
crossref_primary_10_1016_0026_2862_90_90021_I
crossref_primary_10_1097_00024382_200203000_00008
crossref_primary_10_1097_00003246_199903000_00037
ContentType Journal Article
Copyright 1988 American Heart Association, Inc.
Copyright_xml – notice: 1988 American Heart Association, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1161/01.RES.63.2.437
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4571
EndPage 447
ExternalDocumentID 10_1161_01_RES_63_2_437
3396160
00003012-198808000-00018
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: HL-10881
GroupedDBID -
.Z2
01R
08R
0R
1J1
29B
2WC
3RD
40H
41
4Q1
4Q2
4Q3
53G
55
5GY
5RE
5VS
71W
77Y
7O
7O~
AAAXR
AAMOA
AAMTA
AAPBV
AARTV
AAXQO
ABBUW
ABFLS
ABOCM
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACPRK
ACWDW
ACWRI
ACXNZ
ADACO
ADBBV
ADFPA
ADNKB
AE3
AENEX
AFFNX
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
AJNYG
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BAWUL
BOYCO
BQLVK
C1A
C45
CS3
DIK
DU5
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FL-
FRP
FW0
GJ
GX1
H0
H0~
H13
HZ
H~9
IKYAY
IN
IN~
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
LI0
MVM
N9A
N~7
N~B
N~M
O0-
O9-
OAG
OAH
OB2
OCUKA
ODA
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWW
OWY
OXXIT
P-K
P2P
PQEST
PQQKQ
R58
RAH
RHF
RIG
RLZ
RSW
S4R
S4S
UPT
V2I
WH7
WOQ
WOW
X
X3V
X3W
X7M
Z2
ZA5
ZGI
---
-~X
.-D
.3C
.55
.GJ
0R~
18M
1CY
41~
AAAAV
AAGIX
AAHPQ
AAIQE
AAQKA
AASCR
AASOK
ABASU
ABDIG
ABJNI
ABQRW
ABVCZ
ACCJW
ACGFO
ACILI
ACNWC
ACXJB
ADGGA
ADHPY
AE6
AEETU
AFDTB
AGINI
AHOMT
AHQNM
AHRYX
AINUH
AJNWD
AJZMW
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
BS7
CGR
CUY
CVF
DIWNM
ECM
EEVPB
EIF
ERAAH
FCALG
GNXGY
GQDEL
HLJTE
HZ~
IKREB
IPNFZ
NPM
OWU
OWV
OWX
OWZ
T8P
TEORI
TR2
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
YOC
ZFV
ZZMQN
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4148-d897bb366c53553827eb6bce01cdf53a56e860dfc7cb072e238c063a66072233
ISSN 0009-7330
IngestDate Fri Aug 16 00:50:05 EDT 2024
Fri Aug 23 01:42:16 EDT 2024
Sat Sep 28 08:35:11 EDT 2024
Thu Aug 13 19:50:24 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4148-d897bb366c53553827eb6bce01cdf53a56e860dfc7cb072e238c063a66072233
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/01.RES.63.2.437
PMID 3396160
PQID 78315084
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_78315084
crossref_primary_10_1161_01_RES_63_2_437
pubmed_primary_3396160
wolterskluwer_health_00003012-198808000-00018
ProviderPackageCode L-C
C45
7O~
AARTV
ADFPA
OLH
ASCII
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
OVLEI
AJIOK
OPUJH
V2I
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
OB2
ACEWG
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OUVQU
ORVUJ
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
AAMTA
AAAXR
E.X
OWW
OCUKA
OWY
01R
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
FW0
PublicationCentury 1900
PublicationDate 1988-August
PublicationDateYYYYMMDD 1988-08-01
PublicationDate_xml – month: 08
  year: 1988
  text: 1988-August
PublicationDecade 1980
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation research
PublicationTitleAlternate Circ Res
PublicationYear 1988
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
SSID ssj0014329
Score 1.741244
Snippet Recent evidence shows that circulating granulocytes play an important role in capillary stasis and tissue injury. We investigated two aspects of the problem in...
SourceID proquest
crossref
pubmed
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 437
SubjectTerms Animals
Blood Cell Count
Blood Pressure
Blood Vessels - pathology
Blood Volume
Granulocytes - physiology
Heart Rate
Microcirculation
Regional Blood Flow
Shock, Hemorrhagic - pathology
Shock, Hemorrhagic - physiopathology
Title Granulocytes and No-Reflow Phenomenon in Irreversible Hemorrhagic Shock
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003012-198808000-00018
https://www.ncbi.nlm.nih.gov/pubmed/3396160
https://search.proquest.com/docview/78315084
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdZB2NjjH2VZZ9-2MMgKLMlWbYfm7GlbHQwyKDsxUiyTMzaeDgJof3rd2cpjtNu0A2CkwgiO7ofp7vT3e8IeVumWhtWlLTkRlJQeAVVWWipUgXoy7Q0PMJq5JOv8vi7-Hwanw4G_ayl9UqPzeUf60r-R6owBnLFKtl_kGw3KQzAZ5AvXEHCcL2RjKew0axhN7rA4ClGwBc1hR3vrN6MMHULyRVcJmPVIFNTA_A_s2AbntdNM1eg80bLee1Z8bdsBVVjfEevkScC6gLGEyRsXNb0qMHww_6ZkpmfVwWFNzx5n8iF9k00p6MuiPNjY6tSudZTk90wFhL7Bsy-BKJwVXlp2qXA7RRrRhPuj1is16VMUBG7DitbZeu1WdXzeZ3mFI77xW_CwtFwXtfvMmprFsYAz7HkYzbuftdn0r6yw3V5h63HI6M8jHKYIJc8ZzlMcIvcZkkWo-_-5dvuEEpwlm0b8eF_88xQMMH7K0-wb9Rc81TukfubGpMflj_b2oeeBTN7SB541yM4cjh6RAZ28ZjcOfHJFU_ItA-nAEQcdHAKdnAKKnj14BT04BS0cHpKZp8-zj4cU99ngxqB8eQizRKtuZQmBuuTpwz75Ghjw8gUZcxVLG0qw6I0idFhwixYeQYsWyUlfGOcH5IDuL19RgLFmM4iBU4wT4TQSmUJk1apNA4LUepiSN5t1yn_5dhU8r_IZEjebNcxB42Hx1hqYev1Mk9Sjk0MxJAcuuXtpuI8k5EMh4TuLXfuSooxzwIDAIwigtFTajkVovT5zZ_qBbm7g_9LcrBq1vYVWKUr_brFzm8uaYit
link.rule.ids 315,786,790,27957,27958
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Granulocytes+and+no-reflow+phenomenon+in+irreversible+hemorrhagic+shock&rft.jtitle=Circulation+research&rft.au=Barroso-Aranda%2C+J&rft.au=Schmid-Sch%C3%B6nbein%2C+G+W&rft.au=Zweifach%2C+B+W&rft.au=Engler%2C+R+L&rft.date=1988-08-01&rft.issn=0009-7330&rft.eissn=1524-4571&rft.volume=63&rft.issue=2&rft.spage=437&rft.epage=447&rft_id=info:doi/10.1161%2F01.RES.63.2.437&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_01_RES_63_2_437
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7330&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7330&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7330&client=summon